iRadimed
IRMD
228 hedge funds and large institutions have $734M invested in iRadimed in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 86 increasing their positions, 70 reducing their positions, and 20 closing their positions.
70% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 20
31% more call options, than puts
Call options by funds: $2.97M | Put options by funds: $2.27M
23% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 70
5% more funds holding
Funds holding: 217 → 228 (+11)
1.34% more ownership
Funds ownership: 58.35% → 59.69% (+1.3%)
2% more capital invested
Capital invested by funds: $722M → $734M (+$12.2M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$10.1M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
+$6.28M |
| 3 |
DCM
Davidson Capital Management
Corpus Christi,
Texas
|
+$5.49M |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$4.07M |
| 5 |
Millennium Management
New York
|
+$3.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$9.4M |
| 2 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
-$5.32M |
| 3 |
BlackRock
New York
|
-$3.42M |
| 4 |
IP
Isthmus Partners
Madison,
Wisconsin
|
-$2.49M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.33M |
IRMD Hedge Fund Activity: Q1 2026 in Review
228 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q1 2026, worth a combined $734M — up 1.7% from $722M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new IRMD positions and 20 closed out — a net gain of 14 holders — while 86 added to existing stakes and 70 trimmed.
The largest buyer was Two Sigma Investments, adding an estimated $10.1M. The largest seller was Nine Ten Capital Management, cutting an estimated $9.4M.
- 228 institutional investors held iRadimed (IRMD) as of Q1 2026, up from 217 in Q4 2025.
- Funds reported $734M of iRadimed stock for Q1 2026, up 1.7% quarter-over-quarter.
- 34 funds opened new iRadimed positions in Q1 2026 and 20 closed out, a net change of +14 holders.
- The largest iRadimed buyer in Q1 2026 was Two Sigma Investments, an estimated $10.1M added.
- The largest iRadimed seller in Q1 2026 was Nine Ten Capital Management, an estimated $9.4M sold.
Based on aggregated 13F filings for Q1 2026.